[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN103169783A - Medicine for treating anovulatory dysfunctional uterine bleeding - Google Patents

Medicine for treating anovulatory dysfunctional uterine bleeding Download PDF

Info

Publication number
CN103169783A
CN103169783A CN2013100968728A CN201310096872A CN103169783A CN 103169783 A CN103169783 A CN 103169783A CN 2013100968728 A CN2013100968728 A CN 2013100968728A CN 201310096872 A CN201310096872 A CN 201310096872A CN 103169783 A CN103169783 A CN 103169783A
Authority
CN
China
Prior art keywords
parts
medicine
bleeding
dysfunctional uterine
anovulatory dysfunctional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013100968728A
Other languages
Chinese (zh)
Inventor
薛洪喜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2013100968728A priority Critical patent/CN103169783A/en
Publication of CN103169783A publication Critical patent/CN103169783A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine for treating anovulatory dysfunctional uterine bleeding. Common symptom of anovulatory dysfunctional uterine bleeding is irregular metrorrhagia and is represented by irregular menstrual periods, unequal menstrual periods, indefinite or increased menstrual blood volume, and even excessive bleeding. No stomachache or other discomforts are available in the full bleeding period, secondary anemia always occurs when the amount of bleeding is great or the time is long, and excessive bleeding leads to shock. No abnormalities are found in general check-up and gynecologic examination, so that organic lesions of reproductive organ and general lesions are excluded. Ovulation is stopped through endometrium sample pathological examination, progesterone test in luteal phase and examination of basal body temperature. Through long-term research and clinical verification, the inventor finally finds a traditional Chinese medicine oral preparation for treating anovulatory dysfunctional uterine bleeding with better curative effect. The use level of medical components are found by the inventer, and the medicine comprises the components in parts by weight as follows: 10 parts of angelica sinensis, 10 parts of ligusticum wallichii, 10 parts of myrrh, 10 parts of trogopterus dung, 3 parts of pseudo-ginseng, 12 parts of the root bark of the peony tree, 10 parts of the root of red-rooted salvia, 6 parts of donkey-hide gelatin, 15 parts of fried folium artemisiae argyi, 20 parts of cuttle bone, 20 parts of keel and 15 parts of oyster. The medicines are combined, so that the medicines have the synergistic effect, and have the functions of promoting blood circulation to remove blood stasis, nourishing the blood and hemoslasis and regulating menstruation and relieving pain, so that the medicine can effectively treat anovulatory dysfunctional uterine bleeding.

Description

A kind of medicine for the treatment of the anovulatory anovulatory dysfunctional uterine hemorrhage
Technical field
The present invention relates to a kind of Chinese herbal medicine, especially a kind of Chinese herbal medicine for the treatment of the anovulatory anovulatory dysfunctional uterine hemorrhage.
Background technology
The anovulatory anovulatory dysfunctional uterine hemorrhage is apt to occur in adolescence and climacteric, and common sympton is metrorrhagia, shows as the confusion of the menstrual cycle, and menstrual period are different in size, through measuring indefinite or increasing, even bleeds profusely.Hemorrhage general without stomachache or other discomforts during complete, the many or normal secondary anemia of time long time of amount of bleeding, bleeding profusely to cause shock.General physical checkup and gynecologial examination are got rid of genitals and general organic disease without extremely.Endometrial sampling pathologic finding, luteal phase, progesterone was measured or the examination of basal body temperature anovulation, and treatment is take the hormone hemostasis as main, easily repeatedly at present; The operative treatment such as dilatation and curettage or endometrectomy, uterectomy, both bring very large misery to the patient in case of necessity.
Summary of the invention
The inventor is through studying for a long period of time, and the checking repeatedly by clinical trial, finally found the extract oral medicine that is used for the treatment of the anovulatory anovulatory dysfunctional uterine hemorrhage that better curative effect is arranged, and this medicine has the effects such as blood circulation promoting and blood stasis dispelling, nourishing blood and hemoslasis, menstruction regulating and pain relieving.
Technical assignment of the present invention is to provide a kind of Chinese medicine composition of more efficiently treatment anovulatory anovulatory dysfunctional uterine hemorrhage.Medicament selection Radix Angelicae Sinensis Rhizoma Chuanxiong Myrrha Oletum Trogopterori Radix Notoginseng Cortex Moutan Radix Salviae Miltiorrhizae Colla Corii Asini Folium Artemisiae Argyi (parched) Os Sepiae Os Draconis Concha Ostreae of the present invention makes up, and makes each efficacy of drugs produce synergism these drug regimens, thereby can effectively treat the anovulatory anovulatory dysfunctional uterine hemorrhage.Wherein: Radix Angelicae Sinensis: be the root of Umbelliferae herbaceos perennial Radix Angelicae Sinensis.Property is sweet, hot, temperature.Return liver, suffering, spleen, large intestine channel.Have and enrich blood, invigorate blood circulation, pain relieving, regulating menstruation, the effect of loosening bowel to relieve constipation.
Rhizoma Chuanxiong: be the rhizome of Umbelliferae herbaceos perennial Rhizoma Chuanxiong.The property hot, temperature.GUIXIN, Liver Channel.Has blood-activating and qi-promoting, the effect of wind-expelling pain-stopping.
Myrrha: the oleo-gum-resin of oozing out for Burseraceae shrub or arbor myrrh skin zone.The property hot, bitter, flat.GUIXIN, liver, spleen channel.Promoting blood circulation and stopping pain, detumescence and promoting granulation.
Oletum Trogopterori: be the feces of the trogopterus xanthipes Milne-Edwards of flying squirrel section animal.Property is bitter, salty, sweet, temperature.Return Liver Channel.Promoting blood circulation and stopping pain, removing stasis to stop bleeding.
Radix Notoginseng:Root for Araliaceae herbaceos perennial Radix Notoginseng.Property is hot, sweet, little puckery, temperature.Return liver, heart channel.Hemostasia and dissipation blood stasis, reducing swelling and alleviating pain.Main chemical compositions: arasaponin class, dencichine, flavone, saccharide etc.Arasaponin class, flavone have the effect of blood circulation promoting and blood stasis dispelling, improve blood and stick, gather, coagulate state, to endometrial hyperplasia person successful.
Cortex Moutan: be the root bark of Ranunculaceae undershrub plant Paeonia suffruticosa.The property bitter, hot, be slightly cold.Return kidney, liver, heart channel.Has clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, the effect of reducing the asthenic fever.
Radix Salviae Miltiorrhizae: be the root of Labiatae herbaceos perennial Radix Salviae Miltiorrhizae.The property hot, bitter, be slightly cold.GUIXIN, Liver Channel.Has blood circulation promoting and blood stasis dispelling, removing heat from blood eliminating carbuncle, the effect that relieving restlessness is calmed the nerves.
Colla Corii Asini: for the skin of equine species donkey through decoct, the concentrated solid gum of making.The property sweet, flat.Return lung, liver, kidney, heart channel.Enrich blood, lung conscience kidney yin is grown in hemostasis.
Folium Artemisiae Argyi: be the leaf of Compositae herbaceos perennial Chinese mugwort.The property bitter, hot, warm.Return the liver,kidney,spleen warp.Has warming the meridian for stopping bleeding, the effect of dispersing cold for relieving pain.
The Inner shell of Os Sepiae: Wei Wu Quarry section's animal sepiella maindroni de Rochebrune or golden cuttlefish.Property is salty, puckery, tepor.Return liver, kidney channel.Treating spontaneous emission and leukorrhagia, astringing to arrest bleeding, relieving gastric hyperacidity to alleviate stomachache, removing dampness sore.
Os Draconis: for ancient times multiple large mammal such as deer class, bovine, resemble the Skeletal Fossils of class etc. or resemble the fossil of class front tooth.The property sweet, puckery, flat.GUIXIN, liver, kidney channel.Tranquillizing the mind by relieving convulsion, suppressing the hyperactive liver and subsiding YANG is restrained astringent or styptic treatment for spontaneous sweating.
Concha Ostreae: for Ostreidae animal Concha Ostreae shell.Property is salty, puckery, is slightly cold.Return liver, kidney channel.Suppressing the hyperactive liver and subsiding YANG, hard masses softening and resolving is restrained astringent or styptic treatment for spontaneous sweating.
Radix Angelicae Sinensis, Rhizoma Chuanxiong: nourshing blood and promoting blood circulation.Myrrha, Oletum Trogopterori: promoting blood circulation to disperse blood clots and relieves pain.Radix Notoginseng, Cortex Moutan, Radix Salviae Miltiorrhizae: promoting blood flow and remove blood stasis and stop bleeding.Colla Corii Asini, Folium Artemisiae Argyi (parched) nourishing blood and hemoslasis.Os Sepiae, Os Draconis, Concha Ostreae: astringent or styptic treatment for spontaneous sweating hemostasis.
The consumption of drug component of the present invention is also groped to draw through the inventor in a large number, and each amounts of components is for to have curative effect preferably in the following weight proportioning: Radix Angelicae Sinensis 5-15 part, Rhizoma Chuanxiong 3-10 part, Myrrha 3-10 part, Oletum Trogopterori 3-10 part, Radix Notoginseng 3-12 part, Cortex Moutan 6-12 part, Radix Salviae Miltiorrhizae 5-15 part, Colla Corii Asini 5-15 part, Folium Artemisiae Argyi (parched) 3-15 part, Os Sepiae 6-20 part, Os Draconis 15-30 part, Concha Ostreae 10-30 part.
Its best proportioning is: 10 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Chuanxiongs, 10 parts of Myrrhas, 10 parts of Oletum Trogopteroris, 3 parts of Radix Notoginseng, 12 parts of Cortex Moutans, 10 parts of Radix Salviae Miltiorrhizaes, 6 parts, Colla Corii Asini, 15 parts of Folium Artemisiae Argyi (parched), 20 parts of Os Sepiae, 20 parts of Os Draconis, 15 parts of Concha Ostreaes.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations, as pill, powder, tablet, oral liquid etc.For example these crude drug pulverize mix homogeneously can be made powder takes after mixing it with water; Can use decocting, get after filtration filtrate, make oral liquid; Also can directly take decoction in case of necessity.
Medicine of the present invention has the effects such as blood circulation promoting and blood stasis dispelling, nourishing blood and hemoslasis, menstruction regulating and pain relieving, and short treating period is evident in efficacy, without any side effects, according to clinical 200 routine patients being observed statistics, takes 80%, two of one of the medicine of the present invention obvious effective rate course for the treatment of obvious effective rate course for the treatment of 86%.
The specific embodiment
Take following each medicine:
10 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Chuanxiongs, 10 parts of Myrrhas, 10 parts of Oletum Trogopteroris, 3 parts of Radix Notoginseng, 12 parts of Cortex Moutans, 10 parts of Radix Salviae Miltiorrhizaes, 6 parts, Colla Corii Asini, 15 parts of Folium Artemisiae Argyi (parched), 20 parts of Os Sepiae, 20 parts of Os Draconis, 15 parts of Concha Ostreaes.
Said medicine is put in mortar successively grind well, cross 100 mesh sieves, then packing two pouches; When taking one day twice, once a bag, ten days was a course for the treatment of.
The below is the clinical data that the patient uses medicine of the present invention:
One, physical data
Accept patient's totally 200 examples for medical treatment, all make a definite diagnosis through gynecologial examination and ultrasonic examination, its age 20-49 year, average 32 years old.
Two, diagnostic criteria
1, be apt to occur in adolescence and climacteric, common sympton is metrorrhagia, shows as the confusion of the menstrual cycle, and menstrual period are different in size, through measuring indefinite or increasing, even bleeds profusely.Hemorrhage general without stomachache or other discomforts during complete, the many or normal secondary anemia of time long time of amount of bleeding, bleeding profusely to cause shock.2, general physical checkup and gynecologial examination without extremely, are got rid of genitals and general organic disease.3, Endometrial sampling pathologic finding, luteal phase, progesterone was measured or the examination of basal body temperature anovulation.
Three, Therapeutic Method
The patient takes medicine of the present invention, and one day twice, once a bag.
Four, efficacy assessment standard
Produce effects: after finishing the course for the treatment of, clinical symptoms disappears fully.
Take a turn for the better: symptom is alleviated substantially.
Invalid: remission is not obvious.
Five, therapeutic outcome
Treatment time Produce effects (example) Obvious effective rate % Take a turn for the better (example) Improvement rate % Invalid (example) Inefficiency %
One course for the treatment of 160 80 32 16 8 4
Two courses for the treatment of 172 86 10 20 8 4
Model case:
One, Mrs Li, 20 years old, unmarried, the From Shandong Rizhao people, more than patient's the confusion of the menstrual cycle half a year, menorrhagia, dizzy weak, pale complexion, general physical checkup and anus are looked into no abnormality seen, and luteal phase, progesterone was measured or examination of basal body temperature prompting anovulation.Be diagnosed as the anovulatory anovulatory dysfunctional uterine hemorrhage.
Take medicine of the present invention after course for the treatment of, the patient feels symptom obviously to be alleviated, and menstrual cycle transfers to normally, reduces through amount.Continue to take medicine of the present invention after course for the treatment of, menses are normal, continue a course for the treatment of.
Two, Mrs Wang, 45 years old, people from Linyi, Shandong, polymenorrhea companion be through measuring many 3 months, and general physical checkup and gynecologial examination be without extremely, agenosomia official and general organic disease, Endometrial sampling pathologic finding prompting anovulation.Be diagnosed as the anovulatory anovulatory dysfunctional uterine hemorrhage.
Take medicine of the present invention after course for the treatment of, symptom obviously alleviates, and continues to consolidate a course for the treatment of curative effect.

Claims (2)

1. medicine for the treatment of the anovulatory anovulatory dysfunctional uterine hemorrhage is characterized in that it is made by the crude drug of following weight proportion: Radix Angelicae Sinensis 5-15 part, Rhizoma Chuanxiong 3-10 part, Myrrha 3-10 part, Oletum Trogopterori 3-10 part, Radix Notoginseng 3-12 part, Cortex Moutan 6-12 part, Radix Salviae Miltiorrhizae 5-15 part, Colla Corii Asini 5-15 part, Folium Artemisiae Argyi (parched) 3-15 part, Os Sepiae 6-20 part, Os Draconis 15-30 part, Concha Ostreae 10-30 part.
2. medicine according to claim 1 is characterized in that it is made by the crude drug of following weight proportion: 10 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Chuanxiongs, 10 parts of Myrrhas, 10 parts of Oletum Trogopteroris, 3 parts of Radix Notoginseng, 12 parts of Cortex Moutans, 10 parts of Radix Salviae Miltiorrhizaes, 6 parts, Colla Corii Asini, 15 parts of Folium Artemisiae Argyi (parched), 20 parts of Os Sepiae, 20 parts of Os Draconis, 15 parts of Concha Ostreaes.
CN2013100968728A 2013-03-25 2013-03-25 Medicine for treating anovulatory dysfunctional uterine bleeding Pending CN103169783A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013100968728A CN103169783A (en) 2013-03-25 2013-03-25 Medicine for treating anovulatory dysfunctional uterine bleeding

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013100968728A CN103169783A (en) 2013-03-25 2013-03-25 Medicine for treating anovulatory dysfunctional uterine bleeding

Publications (1)

Publication Number Publication Date
CN103169783A true CN103169783A (en) 2013-06-26

Family

ID=48630270

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013100968728A Pending CN103169783A (en) 2013-03-25 2013-03-25 Medicine for treating anovulatory dysfunctional uterine bleeding

Country Status (1)

Country Link
CN (1) CN103169783A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104940713A (en) * 2015-07-30 2015-09-30 华菊 Medicine for treating dysfunctional uterine bleeding and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020160059A1 (en) * 2000-09-13 2002-10-31 Wei Xiao Cinnamomi and poria composition, method to prepare same and uses thereof
WO2002091857A1 (en) * 2001-05-17 2002-11-21 Cyclogen Co., Ltd Health food and method for preparation thereof
CN101703614A (en) * 2009-11-11 2010-05-12 宋爱民 Chinese medicinal decoction for treating dysfunctional uterine bleeding
CN102000247A (en) * 2010-11-24 2011-04-06 林少梅 Oral traditional Chinese medicine decoction for treating uterine bleeding
CN102114157A (en) * 2010-04-21 2011-07-06 胡海舰 Traditional Chinese medicine oral decoction for treating metrorrhagia
CN102552517A (en) * 2011-12-28 2012-07-11 武汉哈瑞医药有限公司 Gynecological sugar-free gynaecopathia treating particle and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020160059A1 (en) * 2000-09-13 2002-10-31 Wei Xiao Cinnamomi and poria composition, method to prepare same and uses thereof
WO2002091857A1 (en) * 2001-05-17 2002-11-21 Cyclogen Co., Ltd Health food and method for preparation thereof
CN101703614A (en) * 2009-11-11 2010-05-12 宋爱民 Chinese medicinal decoction for treating dysfunctional uterine bleeding
CN102114157A (en) * 2010-04-21 2011-07-06 胡海舰 Traditional Chinese medicine oral decoction for treating metrorrhagia
CN102000247A (en) * 2010-11-24 2011-04-06 林少梅 Oral traditional Chinese medicine decoction for treating uterine bleeding
CN102552517A (en) * 2011-12-28 2012-07-11 武汉哈瑞医药有限公司 Gynecological sugar-free gynaecopathia treating particle and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张芬莲: "中医药治疗功能失调性子宫出血的临床体会", 《光明中医》 *
李永来: "《中华名方》", 31 January 2012, 黑龙江科学技术出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104940713A (en) * 2015-07-30 2015-09-30 华菊 Medicine for treating dysfunctional uterine bleeding and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101502634B (en) Chinese medicinal composition for treating uterine blood flow and preparation method thereof
CN103182015B (en) Medicament for treating threatened abortion
CN102342992B (en) Chinese medicinal composition for treating insomnia and preparation method of preparation thereof
CN103585378B (en) A Chinese medicinal composition for treating female infertility, and its preparation method
CN102872418A (en) Medicine for treating pelvic inflammation
CN103169805A (en) Medicament for treating meniscus injury
CN103285368B (en) Chinese medicine composition for treating dysmenorrhea
CN104940810A (en) Traditional Chinese medicine composition for treating angina
CN100525827C (en) Chinese-medicinal composition for treating difficult menstruation
CN102886025A (en) Medicine for treating ectopic pregnancy (undamaged period)
CN102600426A (en) Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof
CN102512564A (en) Traditional Chinese medicine for treating dysmenorrhea
CN103690900B (en) A kind of Chinese medicine for the treatment of dysfunctional uterine hemorrhage
CN104771652A (en) Vertigo treating traditional Chinese medicine composition
CN103169783A (en) Medicine for treating anovulatory dysfunctional uterine bleeding
CN103156943B (en) Medicament for treating infertility of obstructive uterine tube
CN102793845B (en) Traditional Chinese medicine composition for treating climacteric syndrome
CN104306872A (en) Traditional Chinese medicine for treating uterine fibroid
CN103263572B (en) Traditional Chinese medicine composition for treating osteoporosis and preparation method thereof
CN103977133B (en) A kind of Chinese medicine preparation for the treatment of female climacteric syndrome
CN118178584A (en) Traditional Chinese medicine composition for tonifying kidney, promoting blood circulation and nourishing fetus
CN105434767A (en) Traditional Chinese medicine for treating infertility
CN117752753A (en) Traditional Chinese medicine composition for nourishing yin, activating blood and preventing miscarriage
CN105031552A (en) Traditional Chinese medicine composition for treating gynecological tumors
CN105477373A (en) Chinese patent medicine for treating myocardial infarction and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20130626